Gilead Sciences Inc (GILD)
67.72
-0.14
(-0.21%)
USD |
NASDAQ |
May 17, 16:00
67.74
+0.02
(+0.03%)
After-Hours: 20:00
Gilead Sciences Cash from Investing (Quarterly): -2.207B for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.207B |
December 31, 2023 | -727.00M |
September 30, 2023 | -229.00M |
June 30, 2023 | -483.00M |
March 31, 2023 | -826.00M |
December 31, 2022 | -375.00M |
September 30, 2022 | -713.00M |
June 30, 2022 | -308.00M |
March 31, 2022 | -1.07B |
December 31, 2021 | -278.00M |
September 30, 2021 | -234.00M |
June 30, 2021 | -577.00M |
March 31, 2021 | -2.042B |
December 31, 2020 | -8.977B |
September 30, 2020 | -271.00M |
June 30, 2020 | -5.023B |
March 31, 2020 | -344.00M |
December 31, 2019 | 431.00M |
September 30, 2019 | -1.841B |
June 30, 2019 | -6.163B |
March 31, 2019 | -244.00M |
December 31, 2018 | 2.735B |
September 30, 2018 | 2.025B |
June 30, 2018 | 5.241B |
March 31, 2018 | 4.354B |
Date | Value |
---|---|
December 31, 2017 | -10.02B |
September 30, 2017 | -2.114B |
June 30, 2017 | -4.246B |
March 31, 2017 | 307.00M |
December 31, 2016 | -2.675B |
September 30, 2016 | -3.917B |
June 30, 2016 | -3.284B |
March 31, 2016 | -2.109B |
December 31, 2015 | -2.438B |
September 30, 2015 | -4.186B |
June 30, 2015 | -3.552B |
March 31, 2015 | -2.299B |
December 31, 2014 | -405.00M |
September 30, 2014 | -770.00M |
June 30, 2014 | -487.00M |
March 31, 2014 | -161.00M |
December 31, 2013 | 216.76M |
September 30, 2013 | -8.032M |
June 30, 2013 | -55.48M |
March 31, 2013 | -407.26M |
December 31, 2012 | 50.12M |
September 30, 2012 | -518.04M |
June 30, 2012 | -634.96M |
March 31, 2012 | -10.74B |
December 31, 2011 | 4.440B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.977B
Minimum
Dec 2020
431.00M
Maximum
Dec 2019
-1.613B
Average
-645.00M
Median
Cash from Investing (Quarterly) Benchmarks
Bristol-Myers Squibb Co | -19.62B |
Merck & Co Inc | -1.376B |
Pfizer Inc | 1.732B |
AbbVie Inc | -9.588B |
Xilio Therapeutics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 2.219B |
Cash from Financing (Quarterly) | -1.361B |
Free Cash Flow | 7.90B |
Free Cash Flow Per Share (Quarterly) | 1.695 |
Free Cash Flow to Equity (Quarterly) | 1.907B |
Free Cash Flow to Firm (Quarterly) | 2.350B |
Free Cash Flow Yield | 9.30% |